• Craig Carlson

    Craig Carlson is a senior operational executive with strong strategic and financial acumen. Prior to joining BioArts, he was Vice President and CFO of Neurobiological Technologies, Inc. of Emeryville, California, where he raised more than $70m during a difficult economic time; and Sr. Vice President, COO, and CFO of Cygnus, Inc. of Redwood City, California, where he raised more than $250m, led the national launch of the world's first non- invasive glucose monitoring device, established and directed a U.K. subsidiary, and managed the transition from an R&D-driven company to a commercial company. Prior to his biotech experience, Craig worked for 13 years in the advertising industry, his last position being Vice President and Group Director of Young & Rubicam Advertising, San Francisco, California. He is past Chairman and CEO of the San Francisco Advertising Federation. He received a B.A. from Union College, an MS Ed. From Hofstra University, and an M.B.A. from Stanford University.